MARKET INSIGHTS IMS Retail Drug Monitor has moved New hope for hepatitis B Nycomed: meeting challenges head on UCB: Integrating Schwarz Medicare Part D: Implications to date IQWiG Director Discusses New Cost-Effectiveness Methodology Part II: Interview with IQWiG Director	HEADLINES Drug News from IMS LifeCycle R&D Focus - week ending 18th January 2008
NEW TO THIS SITE? Welcome to IMS Global Insights	COMPANY WEB SEARCH Access the IMS Pharma Web Directory

Contact | About Us | Global Website Directory | Privacy | Search | Site Map
Copyright © 2008 IMS Health Incorporated. All rights reserved.